MEDICAMEN BIOTECH . Q3 FY24 Results

MEDICAMEN BIOTECH . has released its financial results for the Q3 quarter of Financial Year 23-2024. Here's a comprehensive breakdown of the company's performance:

Revenue Analysis

• Current Quarter Revenue: Rs. 46.50 Cr
• Quarter-on-Quarter (QoQ) Change: 6.80% (Previous Quarter: Rs. 43.54 Cr )
• Year-on-Year (YoY) Change: 30.69% (Same Quarter Last Year: Rs. 35.58 Cr )

Profitability Metrics

• Net Profit: Rs. 2.03 Cr
• QoQ Profit Change: 37.46% (Previous Quarter: Rs. 1.48 Cr )
• YoY Profit Change: -46.16% (Same Quarter Last Year: Rs. 3.77 Cr )

Shareholder Returns

• Earnings Per Share (EPS): Rs. 1.60
• QoQ EPS Change: 36.75% (Previous Quarter: Rs. 1.17)
• YoY EPS Change: -46.31% (Same Quarter Last Year: Rs. 2.98)

Performance Summary

Mixed

MEDICAMEN BIOTECH . had a complex financial situation. Different parts of the business are performing differently, showing a changing market.

This analysis provides a snapshot of MEDICAMEN BIOTECH .'s financial performance. Investors and analysts should consider these results in the context of broader market trends and the company's long-term strategy.